Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60) by Pfreundschuh, Michael, Prof, Schubert, Joerg, MD, Ziepert, Marita, Dipl-Math, Schmits, Rudolf, MD, Mohren, Martin, MD, Lengfelder, Eva, MD, Reiser, Marcel, MD, Nickenig, Christina, MD, Clemens, Michael, MD, Peter, Norma, MD, Bokemeyer, Carsten, Prof, Eimermacher, Hartmut, MD, Ho, Anthony, Prof, Hoffmann, Martin, MD, Mertelsmann, Roland, Prof, Trümper, Lorenz, Prof, Balleisen, Leopold, MD, Liersch, Ruediger, MD, Metzner, Bernd, MD, Hartmann, Frank, MD, Glass, Bertram, MD, Poeschel, Viola, MD, Schmitz, Norbert, MD, Ruebe, Christian, Prof, Feller, Alfred C, Prof, Loeffler, Markus, Prof

Get full text